electroCore (NASDAQ:ECOR – received rating) announced its earnings results on Thursday. The company reported ($0.08) EPS for the quarter, missing analyst consensus estimates of ($0.05) by ($0.03), MarketWatch Earnings reports. electroCore had a negative return on equity of 57.78% and a negative net margin of 315.87%. For the same period last year, the company posted ($0.11) earnings per share.
shares of NASDAQ:ECOR was traded down $0.01 on Friday to hit $0.39. 960,046 shares of the Company were exchanged compared to an average volume of 283,657. The stock has a market cap of $27.58 million, a price-to-earnings ratio of -1.44 and a beta of 1.04. electroCore has a 12-month low of $0.38 and a 12-month high of $1.85. The company’s 50-day simple moving average is $0.52 and its 200-day simple moving average is $0.66.
A number of equity analysts recently commented on the company. HC Wainwright lowered its price target on electroCore to $2.75 from $3.00 and gave the company a “buy” rating in a report on Wednesday, January 19. Maxim Group took over coverage of electroCore in a report on Friday, March 11th. They gave the company a “buy” rating and a price target of $1.50.
Hedge funds have recently bought and sold shares of the stock. UBS Group AG increased its stake in electroCore by 222.6% in the third quarter. UBS Group AG now owns 25,598 shares of the company, valued at $29,000, after purchasing a further 17,662 shares during the period. Jane Street Group LLC acquired a new position in electroCore valued at approximately $31,000 during the third quarter. Citadel Advisors LLC increased its stake in electroCore by 68.3% during the third quarter. Citadel Advisors LLC now owns 95,832 shares of the company’s stock valued at $108,000 after purchasing an additional 38,879 shares during the period. Millennium Management LLC increased its stake in electroCore by 425.8% in the second quarter. Millennium Management LLC now owns 111,664 shares of the Company’s stock valued at $133,000 after purchasing an additional 90,429 shares during the period. Finally, State Street Corp increased its stake in electroCore by 49.3% in the fourth quarter. State Street Corp now owns 164,500 shares of the company’s stock valued at $96,000 after purchasing an additional 54,300 shares during the period. 18.91% of the shares are currently owned by institutional investors.
About ElectroCore (received rating)
electroCore, Inc, a commercial-stage medical device company, is engaged in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headaches in adults.
Receive news & reviews for electroCore Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for electroCore and related companies with MarketBeat.com’s FREE daily email newsletter.